At-risk coronavirus patients can be identified in advance - study
The study focused on collecting information and samples from hospitalized COVID-19 patients to create a detailed profile of the immune response and to compare their different immune responses.
Tel Aviv startup Immunai aim to map the immune system(photo credit: Courtesy)BySARAH CHEMLA